COVID 19 VACCINE UPDATE

World’s First Intra-Nasal Vaccine for Coronavirus Gets CDSCO’s Approval for Restricted Use

COVID-19 Vaccine Update: Bharat Biotech Gets DCGI Approval For Intranasal Booster Dose for Restricted Use

COVID-19 Vaccine Maker Moderna Sues Pfizer, BioNTech Over Patent Infringement of Its Vaccine

COVID 19 VACCINE UPDATE

World’s First Intra-Nasal Vaccine for Coronavirus Gets CDSCO’s Approval for Restricted Use

COVID-19 Vaccine Update: Bharat Biotech Gets DCGI Approval For Intranasal Booster Dose for Restricted Use

COVID-19 Vaccine Maker Moderna Sues Pfizer, BioNTech Over Patent Infringement of Its Vaccine

COVID-19 Vaccine Update: NTAGI Approves Corbevax, Covaxin for 5-12 Years Age Group, Say Sources

COVID-19 Vaccine Update: 3 Doses Protect Children Under 5, Says Pfizer

COVID-19 Vaccine: Nobody Can Be Forced To Get Vaccinated, Current Policy Not Unreasonable or Arbitrary, Says Supreme Court

COVID-19 Vaccine Update: Bharat Biotech Gets DCGI Approval For Intranasal Booster Dose for Restricted Use

COVID-19 Vaccine Maker Moderna Sues Pfizer, BioNTech Over Patent Infringement of Its Vaccine

COVID-19 Vaccine Update: NTAGI Approves Corbevax, Covaxin for 5-12 Years Age Group, Say Sources

COVID-19 Vaccine Update: 3 Doses Protect Children Under 5, Says Pfizer

COVID-19 Vaccine: Nobody Can Be Forced To Get Vaccinated, Current Policy Not Unreasonable or Arbitrary, Says Supreme Court

COVID-19 Vaccine Update: Subject Expert Panel Recommends Corbevax Vaccine for Children Aged 5-11

COVID-19 Vaccine Update: Govt Panel Recommends Covovax Inclusion in Vaccination Drive for 12 and Above

COVID-19 Vaccine Update: Govt Panel Recommends Permission For Phase 3 Trial of Sputnik Light Vaccine as Booster Dose

COVID-19 Vaccine Update: Subject Expert Panel Recommends Corbevax Vaccine for Children Aged 5-11

COVID-19 Vaccine Update: Govt Panel Recommends Covovax Inclusion in Vaccination Drive for 12 and Above

COVID-19 Vaccine Update: Govt Panel Recommends Permission For Phase 3 Trial of Sputnik Light Vaccine as Booster Dose

South Korea Rolls Out 4th COVID-19 Vaccine Shots For High-Risk Groups Amid Surge In Omicron Infections

COVID-19 Vaccine Update: Bharat Biotech Gets DCGI Approval For Intranasal Booster Dose Trials

COVID-19 Vaccine Update: Moderna Begins Trial of Omicron-Specific Vaccine Booster

COVID-19 Vaccine Update: Govt Panel Recommends Permission For Phase 3 Trial of Sputnik Light Vaccine as Booster Dose

South Korea Rolls Out 4th COVID-19 Vaccine Shots For High-Risk Groups Amid Surge In Omicron Infections

COVID-19 Vaccine Update: Bharat Biotech Gets DCGI Approval For Intranasal Booster Dose Trials

COVID-19 Vaccine Update: Moderna Begins Trial of Omicron-Specific Vaccine Booster

Corbevax, Covovax, Anti-Viral Drug Molnupiravir Approved by Drug Regulator CDSCO In Fight Against COVID-19

Govt Panel Recommends Emergency Use Authorisation for Covovax, Corbevax and Anti-COVID-19 Pill Molnupiravir

COVID-19 Vaccination Update: Requirement, Timing of Coronavirus Vaccine Booster Will Be Based on Scientific Decisions, Says Dr VK Paul

COVID-19 Vaccine Update: Moderna Begins Trial of Omicron-Specific Vaccine Booster

Corbevax, Covovax, Anti-Viral Drug Molnupiravir Approved by Drug Regulator CDSCO In Fight Against COVID-19

Govt Panel Recommends Emergency Use Authorisation for Covovax, Corbevax and Anti-COVID-19 Pill Molnupiravir

COVID-19 Vaccination Update: Requirement, Timing of Coronavirus Vaccine Booster Will Be Based on Scientific Decisions, Says Dr VK Paul

COVID-19 Vaccine Update: Covovax, Vaccine Produced By Serum Institute of India Under License From Novavax, Gets Emergency Use Approval From WHO

Covovax, COVID-19 Vaccine Produced By Serum Institute of India Under Licence From Novavax, Gets WHO Approval For Emergency Use

COVID-19 Vaccine Update: US FDA Authorises Pfizer-BioNTech, Moderna Coronavirus Vaccine Boosters for All Adults

COVID-19 Vaccination Update: Requirement, Timing of Coronavirus Vaccine Booster Will Be Based on Scientific Decisions, Says Dr VK Paul

COVID-19 Vaccine Update: Covovax, Vaccine Produced By Serum Institute of India Under License From Novavax, Gets Emergency Use Approval From WHO

Covovax, COVID-19 Vaccine Produced By Serum Institute of India Under Licence From Novavax, Gets WHO Approval For Emergency Use

COVID-19 Vaccine Update: US FDA Authorises Pfizer-BioNTech, Moderna Coronavirus Vaccine Boosters for All Adults

COVID-19 Vaccine Update: Bahrain Approves Bharat Biotech's COVAXIN For Emergency Use

UK To Add India’s COVID-19 Vaccine Covaxin to Approved List From November 22, No Quarantine For Fully Vaccinated Travellers

COVID-19 Vaccine Update: Bahrain Approves Bharat Biotech's COVAXIN For Emergency Use